Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
Open Access
- 26 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 11 (1), 1-8
- https://doi.org/10.1038/s41398-021-01206-z
Abstract
Mild behavioral impairment (MBI) is suggested as risk marker for neurodegenerative diseases, such as Alzheimer’s disease (AD). Recently, pathologic tau deposition in the brain has been shown closely related to clinical manifestations, such as cognitive deficits. Yet, associations between tau pathology and MBI have rarely been investigated. It is further debated if MBI precedes cognitive deficits in AD. Here, we explored potential mechanisms by which MBI is related to AD, this by studying associations between MBI and tau in preclinical AD. In all, 50 amyloid-β-positive cognitively unimpaired subjects (part of the BioFINDER-2 study) underwent MBI-checklist (MBI-C) to assess MBI, and the Alzheimer’s Disease Assessment Scale – Cognitive subscale (ADAS-Cog) delayed word recall (ADAS-DR) to assess episodic memory. Early tau pathology was determined using tau-PET ([18F]RO948 retention in entorhinal cortex/hippocampus) and cerebrospinal fluid (CSF) P-tau181. Regression models were used to test for associations. We found that higher tau-PET signal in the entorhinal cortex/hippocampus and CSF P-tau181 levels were associated with higher MBI-C scores (β = 0.010, SE = 0.003, p = 0.003 and β = 1.263, SE = 0.446, p = 0.007, respectively). When MBI-C and ADAS-DR were entered together in the regression models, tau-PET (β = 0.009, p = 0.009) and CSF P-tau181 (β = 0.408, p = 0.006) were predicted by MBI-C, but not ADAS-DR. We conclude that in preclinical AD, MBI is associated with tau independently from memory deficits. This denotes MBI as an important early clinical manifestation related to tau pathology in AD.Keywords
This publication has 37 references indexed in Scilit:
- Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal AdultsJournal of Alzheimer's Disease, 2020
- Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948European Journal of Nuclear Medicine and Molecular Imaging, 2019
- The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromesBrain, 2019
- Predicting diagnosis and cognition with 18F‐AV‐1451 tau PET and structural MRI in Alzheimer's diseaseAlzheimer's & Dementia, 2019
- Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive declineInternational Psychogeriatrics, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrumAnnals of Neurology, 2016
- Apathy is Associated With Lower Inferior Temporal Cortical Thickness in Mild Cognitive Impairment and Normal Elderly IndividualsThe Journal of Neuropsychiatry and Clinical Neurosciences, 2015
- Regional Cortical Thinning Predicts Worsening Apathy and Hallucinations Across the Alzheimer Disease SpectrumAmerican Journal of Geriatric Psychiatry, 2013
- An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple SclerosisNeuroImage, 2012